- Documento2022Shah_Infections (1)cargado porrehana
- Documentoch-068-ophthalmia-neonatorumcargado porrehana
- Documentocimb-17-00002cargado porrehana
- DocumentoSadiaPerween2etalcargado porrehana
- DocumentoSadiaPerween2etalcargado porrehana
- DocumentoUntitledcargado porrehana
- DocumentoInt J of Urology - 2009 - Christensen - How to structure research paperscargado porrehana
- DocumentoSpirochete Flagella and Motilitycargado porrehana
- Documentoajidm-1-4-2cargado porrehana
- Documentobialvaei2016cargado porrehana
- Documento2019 Carbapenemases Incargado porrehana
- Documento5_6305379790052394247cargado porrehana
- DocumentoFna 90heroicminutes Referencecargado porrehana
- DocumentoLaboratory Diagnosis of Meningitis (1)cargado porrehana
- DocumentoThe Antibiogram Key Considerations for Its Developmentcargado porrehana
- DocumentoRisk Factors for Disease Progressioncargado porrehana
- DocumentoImplementation of a Sample Pooling Strategy for thecargado porrehana
- Documento20-1955cargado porrehana
- DocumentoRisk factors for disease progressioncargado porrehana
- DocumentoPoolingcargado porrehana
- DocumentoEvaluation of Sample Pooling for Diagnosis of COVID‐19 by Real Time‐PCR_ a Resource‐Saving Combat Strategycargado porrehana
- Documento20-1955cargado porrehana
- DocumentoEtiological and Epidemiological Features of Acutecargado porrehana
- DocumentoA Look Inside Oral Sampling for Detection of Non-Oralcargado porrehana
- DocumentoCategory_ Thesis Writing - Elite Editingcargado porrehana
- DocumentoThesis Publication _ International Journal of Research (IJR)cargado porrehana
- Documentop 2003 Generalised Ceacargado porrehana
- DocumentoWHO_HTM_TB_2008.392_engcargado porrehana
- Documentop 2003 Generalised Ceacargado porrehana
- DocumentoSeries 7 Cost-effectiveness of Tuberculosis Controlcargado porrehana
- DocumentoDSTslides_updated_FINALcargado porrehana
- DocumentoSeries 9 Number 9 in This Seriescargado porrehana
- DocumentoTukul TB Diagnosiscargado porrehana
- DocumentoWho Guide Tocargado porrehana
- Documentoseries 5 Should tuberculosis treatment and controlcargado porrehana
- Documentoseries 2 Annual risk of infection with Mycobacteriumcargado porrehana
- Documento7 Series ‘‘Controversial Issues in Tuberculosis’’cargado porrehana
- Documento7 SERIES ‘‘CONTROVERSIAL ISSUES IN TUBERCULOSIS’’cargado porrehana
- Documento4 Series Drug-susceptibility Testing in Tuberculosiscargado porrehana
- Documentopone.0008341cargado porrehana
- Documentoejifcc-19-203 (2)cargado porrehana
- Documentodiagnostic odds ratio [DOR])cargado porrehana
- DocumentoDiagnostic accuracy Part 1 Basic concepts sensitivity and specificity ROC analysis STARD statementcargado porrehana
- DocumentoCalculate Agreement Formula _ Beetroot Design Groupcargado porrehana
- Documentos12879-021-05884-4cargado porrehana
- DocumentoThe MODS method for diagnosis of tuberculosis and multidrug resistant 3cargado porrehana
- DocumentoEPIDEMIOLOGY Of TUBERCULOSIS AND HUMAN IMMUNODEFICIENCYcargado porrehana
- DocumentoDiscordance of Drug Susceptibility Test Data between the CDC Mycocargado porrehana
- Documento40794_2018_Article_75cargado porrehana